Many recent studies have examined the sialic acid content of serum or urine in various pathological states. We have briefly reviewed the substances which contribute to the observed total sialic acid concentration, and given an overview of assay methods used.
Three major areas of clinical interest in sialic acid metabolism are discussed. Serum total sialic acid, ‘lipid-bound’ and ‘protein bound’ sialic acid have all been proposed as tumour markers; but the usefulness of any of these tests is severely limited by changes due to accompanying inflammatory processes. Serum total sialic acid is not a valuable simple marker of an acute phase response. Urinary free and bound sialic acid measurements should be included in screening protocols for inherited disorders of lysosomal metabolism. Current developments in research and potential applications within the clinical biochemistry laboratory are briefly discussed.
SchauerR.Analysis of sialic acids. Meth Enzymol1987; 138: 132–61.
2.
PaulsonJC. Glycoproteins: What are the sugar chains for?Trends Biochem Sci1989; 14: 272–6.
3.
GorogPPearsonJD. Sialic acid moieties on surface glycoproteins protect endothelial cells from proteolytic damage. J Pathol1985; 146: 205–12.
4.
SalhanickAIAmatrudaJM. Role of sialic acid in insulin action and the insulin resistance of diabetes mellitus. Am J Physiol1988; 255: E173–9.
5.
OzbenT.Elevated serum and urine sialic acid levels in renal diseases. Ann Clin Biochem1991; 28: 44–8.
6.
TominoYInoueWYagameMNomotoYSakaiHItoKMeasurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. J Diabetic Complications1988; 2: 175–8.
7.
BhideSParekhAJDesaiMP. Sialic acid levels in serum and CSF in infectious and non-infectious conditions. Biochem Med1977; 18: 99–101.
8.
OnatTEgilmezNCimrinA.Concentrations of sialic acid in serum in Behcet disease. Clin Chem1990; 36: 393.
9.
StefenelliNKlotzHEngelABauerP.Serum sialic acid in malignant tumours, bacterial infections, and chronic liver diseases. J Cancer Res Clin Oncol1985; 109: 55–9.
10.
ShambergerR.Serum sialic acid in normals and cancer patients. J Clin Chem Clin Biochem1984; 22: 647–51.
11.
LindbergGEklundGAGullbergBRastamL.Serum sialic acid concentration and cardiovascular mortality. BMJ1991; 302: 143–6.
12.
BernsGKennedyRO. A study of N-acetylneuraminic acid in relation to its potential as a marker of tumour development. Biochem Soc Trans1990; 18: 333–4.
13.
BaggioBBrianiGCicerelloEGambaroGBruttomessoDTiengoAUrinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in non-albuminuric diabetic patients. Nephron1986; 43: 187–90.
14.
CardoPPLombardoCGattiR.A simple detection of sialic acid storage disorders by urinary “free” and “total” sialic acid determination. Clin Chim Acta1985; 150: 129–33.
15.
RosenbergASchengrundC-L. (eds). Biological Roles of Sialic Acid. New York: Plenum, 1976; 275–94.
16.
SennHJOrthMFitzkeEWielandHGerdeW.Gangliosides in normal human serum—concentration, pattern and transport by lipoproteins. Eur J Biochem1989; 181: 657–62.
17.
KunduSDiegoIOsovitzSMarcusD.Glycosphingolipids of human plasma. Arch Biochem Biophys1985; 238: 388–400.
18.
SeppalaRRenlundMBernardiniITietzeFGahlWA. Renal handling of free sialic acid in normal humans and patients with Salla disease or renal disease. Lab Invest1990; 63: 197–202.
19.
SugiyamaNSaitoKIMizuKItoMNagaiY.A high precision selective determination method for free N-acetylneuraminic acid in human serum. Anal Biochem1988; 170: 140–4.
StevensonRELubinskyMTaylorHAWengerDASchroerRJOlmsteadPM. Sialic acid storage disease with sialuria: Clinical and biochemical features in the severe infantile type. Paediatrics1983; 72: 441–9.
22.
ParkinnenJFinneJ.Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur J Biochem1983; 136: 355–61.
23.
KanzakiTYoketaMMizunoNMatsumotoYHirabayashiY.Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum. Lancet1989; i: 875–7.
24.
Van PeltJVan BilsenDGJLKamerlingJPVliegenthartJFG. Structural analysis of O-glycosidic type of sialyloligosaccharide alditols derived from urinary glycopeptides of a sialidosis patient. Eur J Biochem1988; 174: 183–7.
KnightJAPieperRKMcClellanL.Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation. Clin Chem1988; 34: 2433–8.
27.
KuwaharaS.Carbohydrate interference in assays based on the periodate-coupled thiobarbituric acid reagent. Anal Biochem1980; 101: 54–60.
28.
RobozJSuttajitMBekesiJG. Elimination of 2-deoxyribose interference in the thiobarbituric acid determination of N-acetylneuraminic acid in tumor cells by pH-dependent extraction with cyclohexanone. Anal Biochem1981; 110: 380–8.
29.
KattermanRKriegerR.Mikromethode zur Bestimmung von N-Acetyl-Neuraminsaure in Glykoproteinen (Eng. Abstr.). J Clin Chem Clin Biochem1981; 19: 31–34.
30.
LorentzKWeissTKraasE.Sialic acid in human serum and cerebrospinal fluid-comparison of methods and reference values. J Clin Chem Clin Biochem1986; 24: 189–98.
31.
SvennerholmL.Quantitative estimation of sialic acids: A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta1957; 24: 604–11.
32.
SvennerholmL.Sialic acids and derivatives: Estimation by the ion-exchange method. Meth Enzymol1963; 6: 459–62.
33.
YaoKUbakaT.Determination of sialic acids by acidic ninhydrin reaction. Acta Med Okayama1987; 41: 237–41.
34.
YaoKUbakaTMasuokaNKinutaMIkedaT.Direct determination of bound sialic acids in sialoglycoproteins by acidic ninhydrin reaction. Anal Biochem1989; 179: 332–5.
35.
JourdianGDeanLRosemanS.A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem1971; 246: 430–5.
36.
SchauerR.Characterisation of sialic acids. Meth Enzymol1978; 50: 64–89.
37.
HammondKPapermasterD.Fluorimetric assay of sialic acid in the picomole range: A modification of the thiobarbituric acid assay. Anal Biochem1976; 74: 292–7.
38.
ClementsPRTaylorJAHopwoodJJ. Biochemical characterisation of patients and prenatal diagnosis of sialic acid storage disease for three families. J Inher Metab Dis1988; 11: 30–43.
TaniuchiKChifuKHayashiNNakamachiYYamaguchiNMiyamotoYA new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J Med Sci1981; 27: 91–102.
PowellLDHartGW. Quantitation of picomole levels of N-acetyl- and N-glycolyl-neuraminic acids by a HPLC-adaptation of the thiobarbituric acid assay. Anal Biochem1986; 157: 179–85.
43.
WangW-TErlanssonKLindhFLundgrenTZopfD.High-performance liquid chromatography of sialic acid-containing oligosaccharides and acidic monosaccharides. Anal Biochem1990; 190: 182–7.
44.
KaramanosNKWikstromBAntonopolousCAHjerpeA.Determination of N-acetyl- and N-glycolyl-neuraminic acids in glycoconjugates by reversed-phase hplc with UV detection. J Chromatogr1990; 503: 421–9.
45.
ManziAEDiazSVarkiA.Hplc of sialic acid on a pellicular resin anion-exchange column with pulsed amperometric detection: A comparison with six other systems. Anal Biochem1990; 188: 20–32.
46.
HolzhauserRFaillardH.Sialic acids in human lymphocytes. Qualitative and quantitative alterations in cancer cases. Carbohydrate Res1988; 183: 89–95.
47.
DiazSHigaHHayesBKVarkiA.O-acetylation and de-O acetylation of sialic acids. 7- and 9–0-acetylation of alpha 2,6-linked sialic acids on endogenous N-linked glycans in rat liver Golgi vesicles. J Biol Chem1989; 264: 19416–26.
48.
ShuklaASchauerR.Analysis of sialidase and N-acetyl neuraminate pyruvate-lyase substrate specificity by high-performance liquid chromatography. Anal Biochem1986; 158: 158–64.
49.
SilverHKarimKGrayMJSalinasFA. High performance liquid chromatographic quantitation of N-acetylneuraminic acid in malignant melanoma and breast carcinoma. J Chromatogr1981; 224: 381–8.
50.
ShuklaASchauerR.Analysis of N,O-acetylated N-acetylneuraminic acid by high performance liquid chromatography. J Chromatogr1982; 244: 81–9.
GavellaMLipovacVMrzljakV.Lipid-bound sialic acid in diabetes. Horm Metab Res1989; 21: 280–1.
63.
VoigtmannRPokornyJMeinshausenA.Evaluation and limitations of the lipid-associated sialic acid test for the detection of human cancer. Cancer1989; 64: 2279–83.
64.
ShahangianSFritscheHHughesJIFoemmelRSKatopodisN.Plasma protein-bound sialic acid in patients with colorectal polyps of known histology. Clin Chem1991; 37: 200–4.
ChambersRE. Acute phase proteins. In: LinHJSwaminathanRRobertshawAM, eds. Proceedings of the Fourth Asian-Pacific Congress of Clinical Biochemistry; 1988 Aug 28–Sept 2; Hong Kong: Gardiner-Caldwell Communications Ltd, 1988: 378–80.
67.
LowdenJAO'BrienJS. Sialidosis: A review of human neuraminidase deficiency. Am J Hum Genet1979; 31: 1–18.
68.
Ulrich-BottBKlemBKaiserRSprangerJCantzM.Lysosomal sialidase deficiency: Increased ganglioside content in autopsy tissues of a sialidosis patient. Enzyme1987; 38: 262–6.
69.
YoungIYoungEMossmanJFielderJMooreJ.Neuraminidase deficiency: Case report and review of the phenotype. J Med Genet1987; 24: 283–90.
70.
GaljartNJGillemansNHarrisAvan der HorstGTJVerheijenFWGaljaardHExpression of cDNA encoding the human “protective protein” associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases. Cell1988; 54: 755–64.
71.
HasilikAWaheedAvon FiguraK.Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell disease. Biochem Biophys Res Commun1981; 98: 761–7.
72.
NolanCSlyW.I-cell disease and pseudo-Hurler polydystrophy: Disorders of lysosomal enzyme phosphorylation and localisation. In: ScriverCRBeaudetALSlyWSValleD, eds. The Metabolic Basis of Inherited Disease, 6th edn.New York: McGraw Hill, 1989: 1589–601.
73.
FrischANeufeldEF. A rapid and sensitive assay for neuraminidase: Application to cultured fibroblasts. Anal Biochem1979; 95: 222–7.
74.
OkadaSKatoTMiuraSYabuuchiHNishigakiMKobataAChiyoHHypersialyloligosacchariduria in mucolipidoses: A method for diagnosis. Clin Chim Acta1978; 86: 159–67.
75.
HirabayashiYMatsumotoYMatsumotoMToidaTIidaNMatsubaraTIsolation and characterisation of major urinary amino acid O-glycosides and a dipeptide O-glycoside from a new lysosomal storage disorder (Kanzaki disease)—excessive excretion of serine- and threonine-linked glycan in the patient urine. J Biol Chem1990; 265: 1693–701.
76.
HancockLWThalerMMHorwitzALDawsonG.Generalised N-acetylneuranimic acid storage disease: Quantitation and identification of the monosaccharide accumulating in brain and other tissues. J Neurochem1982; 38: 803–9.
77.
RenlundMAulaPRaivioKAutioSSaimoKRapolaJSalla disease: A new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology1983; 33: 57–66.
78.
TietzeFSeppalaRRenlundMHopwoodJHarperGThomasGDefective lysosomal egress of free sialic acid (NANA) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem1989; 264: 15316–22.
79.
ManciniGde JongeHGaljaardHVerheijenF.Characterisation of a proton-driven carrier for sialic acid in the lysosomal membrane. J Biol Chem1989; 264: 15247–54.
80.
ThomasGHScoccaJMillerCSReynoldsL.Evidence for non-lysosomal storage of N-acetylneuraminic acid (sialic acid) in sialuria fibroblasts. Clin Genet1989; 36: 242–9.
81.
WeissPTietzeFGahlWASeppalaRAshwellG.Identification of the metabolic defect in sialuria. J Biol Chem1989; 264: 17635–6.
SewellAC. The simple detection of neuraminic acid-containing oligosaccharides in patients with glycoprotein storage diseases. J Inher Metab Dis1983; 6: 153–7.
84.
HumbelRCollartM.Oligosaccharides in urine of patients with glycoprotein storage disease. 1-Rapid detection by thin-layer chromatography. Clin Chim Acta1975; 60: 143–5.
85.
SewellAC. An improved thin-layer chromatographic method for urinary oligosaccharide screening. Clin Chim Acta1979; 92: 411–4.
86.
CooperASardharwallaIBThornleyMWardKP. Infantile sialic acid storage disease in two siblings. J Inher Metab Dis1988; 11 (Suppl 2): 259–62.
87.
MendlaKCantzM.Specificity studies on the oligosaccharide neuraminidase of human fibroblasts. Biochem J1984; 218: 625–8.
88.
ManciniGMSBeerensCEMTAulaPPVerheijenFW. Sialic acid storage diseases: A multiple lysosomal transport defect for acidic monosaccharides. J Clin Invest1991; 87: 1329–35.
89.
Den TandtWRBrossmerR.Determination of methylumbelliferyl-N-acetylneuraminic acid sialidase for clinical purposes. J Clin Chem Clin Biochem1984; 22: 189–93.
90.
WilckenBDaiNGreenawayRHammondJSosulaL.Sialuria: A second case. J Inher Metab Dis1987; 10: 97–102.
91.
Kelly-MouleSPeakMThompsonSTurnerGA. Studies of the sialylation and microheterogeneity of human serum α1 acid glycoprotein in health and disease. Clin Chim Acta1987; 166: 177–85.
92.
Kwoh-GainIFletcherLMPriceJPowellLWHallidayJW. Desialylated transferrin and mitochondrial aspartate aminotransferase compared as laboratory markers of excessive alcohol consumption. Clin Chem1990; 36: 841–5.
93.
Cohen-ForterreLAndreJMozereGPeyrouxJSternbergM.Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats. Biochem Pharmacol1990; 40: 507–13.
94.
MorgenthalerJKemmnerWBrossmerR.Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumourigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT1166. Biochem Biophys Res Commun1990; 171: 860–6.
95.
SpiessM.The asialoglycoprotein receptor: A model for endocytic transport receptors. Biochemistry1990; 29: 10009–18.
96.
OrekhovANTertovWMukhinDNMikhailentoIA. Modification of LDL by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun1989; 162: 206–11.
